Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Familial hyperkalemia and hypertension and a hypothesis to explain proximal renal tubular acidosis.

Farfel Z, Mayan H, Karlish SJD.

Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16173-16174. doi: 10.1073/pnas.1909494116. Epub 2019 Aug 1. No abstract available.

PMID:
31371517
2.

Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study.

Spector SR, Mayan H, Loebstein R, Markovits N, Priel E, Massalha E, Shafir Y, Gueta I.

Sci Rep. 2019 Mar 5;9(1):3554. doi: 10.1038/s41598-019-39257-4.

3.

Renal Mg handling, FXYD2 and the central role of the Na,K-ATPase.

Mayan H, Farfel Z, Karlish SJD.

Physiol Rep. 2018 Sep;6(17):e13843. doi: 10.14814/phy2.13843. Review.

4.

Hypermagnesuria in Humans Following Acute Intravenous Administration of Digoxin.

Abu-Amer N, Priel E, Karlish SJD, Farfel Z, Mayan H.

Nephron. 2018;138(2):113-118. doi: 10.1159/000481468. Epub 2017 Oct 30.

PMID:
29169235
5.

Gender differences in mortality among statin users aged 80 years or more.

Justo D, Tchernichovsky M, Kremer A, Joffe E, Sherman S, Ioffe M, Mayan H.

Z Gerontol Geriatr. 2018 Dec;51(8):882-888. doi: 10.1007/s00391-017-1335-y. Epub 2017 Nov 7.

PMID:
29116376
6.

Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.

Kliuk-Ben Bassat O, Carmon V, Hanukoglu A, Ganon L, Massalha E, Holtzman EJ, Farfel Z, Mayan H.

Nephron. 2017;137(1):77-84. doi: 10.1159/000475825. Epub 2017 May 17.

PMID:
28511177
7.

Methotrexate toxicity-response.

Kivity S, Zafrir Y, Loebstein R, Mouallem M, Mayan H.

Autoimmun Rev. 2016 Dec;15(12):1199. doi: 10.1016/j.autrev.2016.04.007. Epub 2016 Apr 19. No abstract available.

PMID:
27101928
8.

Hypercalciuria in familial hyperkalemia and hypertension with KLHL3 mutations.

Mayan H, Carmon V, Oleinikov K, London S, Halevy R, Holtzman EJ, Tenenbaum-Rakover Y, Farfel Z, Hanukoglu A.

Nephron. 2015;130(1):59-65. doi: 10.1159/000381563. Epub 2015 Apr 22.

PMID:
25925082
9.

Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.

Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H.

Autoimmun Rev. 2014 Nov;13(11):1109-13. doi: 10.1016/j.autrev.2014.08.027. Epub 2014 Aug 27. Review.

PMID:
25172240
10.

Recurrent hospitalizations with moderate to severe hyponatremia in older adults and its associated mortality.

Gefen S, Joffe E, Mayan H, Justo D.

Eur J Intern Med. 2014 Sep;25(7):624-8. doi: 10.1016/j.ejim.2014.06.020. Epub 2014 Jul 4.

PMID:
25002082
11.

"Body packers" in Israel: a case series.

Markovits N, Kurnik D, Halkin H, Guranda L, Cohen A, Katz M, Olchovsky D, Mayan H, Loebstein R.

Isr Med Assoc J. 2013 Oct;15(10):639-45.

12.

Nilotinib-associated acute pancreatitis.

Engel T, Justo D, Amitai M, Volchek Y, Mayan H.

Ann Pharmacother. 2013 Jan;47(1):e3. doi: 10.1345/aph.1R334. Epub 2013 Jan 8.

PMID:
23300151
13.

Digoxin-associated decrease in parathyroid hormone (PTH) concentrations in patients with atrial fibrillation.

Apel A, Rachel P, Cohen O, Mayan H.

Eur J Clin Invest. 2013 Feb;43(2):152-8. doi: 10.1111/eci.12026. Epub 2012 Dec 14.

PMID:
23240707
14.

Cyclosporine metabolic side effects: association with the WNK4 system.

Melnikov S, Mayan H, Uchida S, Holtzman EJ, Farfel Z.

Eur J Clin Invest. 2011 Oct;41(10):1113-20. doi: 10.1111/j.1365-2362.2011.02517.x. Epub 2011 Mar 24.

PMID:
21434893
15.

Effect of age and affection status on blood pressure, serum potassium and stature in familial hyperkalaemia and hypertension.

Farfel A, Mayan H, Melnikov S, Holtzman EJ, Pinhas-Hamiel O, Farfel Z.

Nephrol Dial Transplant. 2011 May;26(5):1547-53. doi: 10.1093/ndt/gfq612. Epub 2010 Oct 18.

PMID:
20956807
16.

The serotonin syndrome: initial misdiagnosis.

Attar-Herzberg D, Apel A, Gang N, Dvir D, Mayan H.

Isr Med Assoc J. 2009 Jun;11(6):367-70.

17.

Familial hyperkalemia and hypertension: pathogenetic insights based on lithium clearance.

Mayan H, Melnikov S, Novikov I, Holtzman EJ, Farfel Z.

J Clin Endocrinol Metab. 2009 Aug;94(8):3010-6. doi: 10.1210/jc.2008-2572. Epub 2009 Jun 2.

PMID:
19491230
18.

Distinct pathways for the involvement of WNK4 in the signaling of hypertonicity and EGF.

Shaharabany M, Holtzman EJ, Mayan H, Hirschberg K, Seger R, Farfel Z.

FEBS J. 2008 Apr;275(8):1631-42. doi: 10.1111/j.1742-4658.2008.06318.x. Epub 2008 Feb 27.

19.

Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension.

Mayan H, Attar-Herzberg D, Shaharabany M, Holtzman EJ, Farfel Z.

Nephrol Dial Transplant. 2008 Feb;23(2):492-6. Epub 2007 Oct 19.

PMID:
17951312
20.

Hyperglobulinemia in amiodarone-induced pneumonitis.

Mouallem M, Antipov N, Mayan H, Sela BA, Farfel Z.

Cardiovasc Drugs Ther. 2007 Feb;21(1):63-7. Epub 2007 Mar 15.

PMID:
17357845
21.

Successful thalidomide treatment of persistent chylous pleural effusion in disseminated lymphangiomatosis [corrected].

Pauzner R, Mayan H, Waizman A, Rozenman J, Farfel Z.

Ann Intern Med. 2007 Jan 2;146(1):75-6. No abstract available. Erratum in: Ann Intern Med. 2007 Mar 6;146(5):396.

PMID:
17200231
22.

A patient with abdominal pain, vomiting and splenomegaly.

Reinstein E, Pauzner R, Mayan H, Schiby G.

Isr Med Assoc J. 2006 Jun;8(6):435-8. No abstract available.

23.

WNK4 regulates airway Na+ transport: study of familial hyperkalaemia and hypertension.

Farfel Z, Mayan H, Yaacov Y, Mouallem M, Shaharabany M, Pauzner R, Kerem E, Wilschanski M.

Eur J Clin Invest. 2005 Jun;35(6):410-5.

PMID:
15948903
24.

Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation.

Mayan H, Mouallem M, Shaharabany M, Pauzner R, Farfel Z.

Am J Obstet Gynecol. 2005 Feb;192(2):598-603.

PMID:
15696009
25.

Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.

Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, Holtzman EJ, Farfel Z.

J Clin Endocrinol Metab. 2004 Aug;89(8):4025-30.

PMID:
15292344
26.

Suppression of gamma-melanocyte-stimulating hormone secretion is accompanied by salt-sensitive hypertension in the rat.

Mayan H, Ni XP, Almog S, Humphreys MH.

Hypertension. 2003 Nov;42(5):962-7. Epub 2003 Oct 20.

PMID:
14568996
27.

Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome.

Pauzner R, Dulitzky M, Carp H, Mayan H, Kenett R, Farfel Z, Many A.

J Thromb Haemost. 2003 Aug;1(8):1758-63.

28.

Therapeutic drug monitoring of theophylline in frail elderly patients: oral compared with nasogastric tube administration.

Berkovitch M, Dafni O, Leiboviz A, Mayan H, Habut B, Segal R.

Ther Drug Monit. 2002 Oct;24(5):594-7.

PMID:
12352930
29.
30.

Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.

Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z.

J Clin Endocrinol Metab. 2002 Jul;87(7):3248-54.

PMID:
12107233
31.

Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure.

Mayan H, Kantor R, Rimon U, Golubev N, Heyman Z, Goshen E, Shalmon B, Weiss P.

Liver. 2001 Oct;21(5):361-4. Review.

PMID:
11589774
32.

Trans-tubular potassium gradient in patients with drug-induced hyperkalemia.

Mayan H, Kantor R, Farfel Z.

Nephron. 2001 Sep;89(1):56-61.

PMID:
11528233
33.

Human hypertension caused by mutations in WNK kinases.

Wilson FH, Disse-Nicodème S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP.

Science. 2001 Aug 10;293(5532):1107-12.

34.

Lithium intoxication due to carbamazepine-induced renal failure.

Mayan H, Golubev N, Dinour D, Farfel Z.

Ann Pharmacother. 2001 May;35(5):560-2.

PMID:
11346062
35.

Acute respiratory failure with massive pulmonary infiltrates six weeks after coronary artery bypass operation.

Mayan H, Kantor R, Wollner A, Farfel Z.

Isr Med Assoc J. 2001 Jan;3(1):67-8. No abstract available.

36.

[Acquired hemophilia].

Kantor R, Mayan H, Yaron D.

Harefuah. 2000 May 15;138(10):860-4. Review. Hebrew. No abstract available.

PMID:
10883255
37.

Acquired hemophilia masked by warfarin therapy.

Kantor R, Mayan H, Puritz L, Varon D, Farfel Z.

Am J Med Sci. 2000 Mar;319(3):197-201. Review.

PMID:
10746834
38.

Kaposi's sarcoma after lung transplantation in a Sephardic Jewish woman.

Kantor R, Mayan H, Shalmon B, Reichert N, Farfel Z.

Dermatology. 2000;200(1):49-50.

PMID:
10681615
39.

The pharmacokinetics of morphine and lidocaine in nine severe trauma patients.

Berkenstadt H, Mayan H, Segal E, Rotenberg M, Almog S, Perel A, Ezra D.

J Clin Anesth. 1999 Dec;11(8):630-4.

PMID:
10680103
40.

Endotracheal tolazoline: pharmacokinetics and pharmacodynamics in dogs.

Paret G, Eyal O, Mayan H, Gilad E, Ben-Abraham R, Ezra D, Barzilay Z.

Acta Paediatr. 1999 Sep;88(9):1020-3.

PMID:
10519347
41.

Atropine pharmacokinetics and pharmacodynamics following endotracheal versus endobronchial administration in dogs.

Paret G, Mazkereth R, Sella R, Almog S, Mayan H, Lotan D, Ben-Abraham R, Barzilay Z, Ezra D.

Resuscitation. 1999 Jun;41(1):57-62.

PMID:
10459593
42.

Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor.

Mayan H, Hourvitz A, Schiff E, Farfel Z.

Nephrol Dial Transplant. 1999 Jul;14(7):1764-6. No abstract available.

PMID:
10435892
43.

Pharmacokinetics of endobronchial tolazoline administration in dogs.

Paret G, Eyal O, Mayan H, Ben-Abraham R, Vardi A, Manisterski Y, Barzilay Z, Ezra D.

Am J Perinatol. 1999;16(1):1-6.

PMID:
10362074
44.

The pharmacokinetics of morphine and lidocaine in critically ill patients.

Berkenstadt H, Segal E, Mayan H, Almog S, Rotenberg M, Perel A, Ezra D.

Intensive Care Med. 1999 Jan;25(1):110-2.

PMID:
10051088
45.

[Salt--hypertension and other possible adverse effects].

Farfel Z, Mayan H.

Harefuah. 1997 Aug;133(3-4):99-100. Review. Hebrew. No abstract available.

PMID:
9332073
46.

Epinephrine pharmacokinetics and pharmacodynamics following endotracheal administration in dogs: the role of volume of diluent.

Paret G, Vaknin Z, Ezra D, Peleg E, Rosenthal T, Vardi A, Mayan H, Barzilay Z.

Resuscitation. 1997 Aug;35(1):77-82.

PMID:
9259064
47.

Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.

Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP.

Nat Genet. 1997 Jun;16(2):202-5.

PMID:
9171836
48.

Multiple spurious laboratory results in a patient with hyperlipemic pancreatitis treated by plasmapheresis.

Mayan H, Gurevitz O, Mouallem M, Farfel Z.

Isr J Med Sci. 1996 Sep;32(9):762-6.

PMID:
8865833
49.

Dietary sodium intake modulates pituitary proopiomelanocortin mRNA abundance.

Mayan H, Ling KT, Lee EY, Wiedemann E, Kalinyak JE, Humphreys MH.

Hypertension. 1996 Aug;28(2):244-9.

PMID:
8707389
50.

Sympathomimetic effects of paraxanthine and caffeine in humans.

Benowitz NL, Jacob P 3rd, Mayan H, Denaro C.

Clin Pharmacol Ther. 1995 Dec;58(6):684-91.

PMID:
8529334

Supplemental Content

Support Center